Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis

BACKGROUND: Vonoprazan is a novel potassium‐competitive acid blocker which may provide clinical benefit in acid‐related disorders. AIM: To verify the non‐inferiority of vonoprazan vs. lansoprazole in patients with erosive oesophagitis (EE), and to establish its long‐term safety and efficacy as maint...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashida, K., Sakurai, Y., Hori, T., Kudou, K., Nishimura, A., Hiramatsu, N., Umegaki, E., Iwakiri, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Randomised Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738414/
https://www.ncbi.nlm.nih.gov/pubmed/26559637
http://dx.doi.org/10.1111/apt.13461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738414/
https://www.ncbi.nlm.nih.gov/pubmed/26559637
http://dx.doi.org/10.1111/apt.13461

Ejemplares similares